About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Texas | 1,777 Studies

Clinical Trials Breast CancerTexas

Breast Cancer Clinical Trials in Texas

Find 1,777 clinical trials for breast cancer near Texas. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1201-1220 of 1,777 trials

Active not recruitingRadiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast CancerThis phase II trial studies how well radiation therapy before surgery works in treating patients with hormone receptor positive, HER2 negative breast cancer.NCT03359954·Houston, Texas CompletedDurvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast CancerThis early phase I trial studies the side effects of durvalumab and tremelimumab before surgery in treating patients with hormone receptor positive, HER2 negative stage II-III…NCT03132467·Houston, Texas WithdrawnTest - Retest Reproducibility of 18F Fluoroestradiol (FES) PETThis study will formally address the hypothesis that FES-PET/CT measurement of ER expression predicts clinical benefit of first-line endocrine therapy in newly diagnosed ER+…NCT03065712·Dallas, Texas CompletedStudy Comparing the Pharmacokinetics of FTD as a Component of TAS-102 With FTD AloneThe purpose of this study is to compare the pharmacokinetics of trifluorothymidine (FTD) as a component of TAS-102 with FTD alone.NCT01867866·San Antonio, Texas

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedTesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBCCONTESSA 2 is a multinational, multicenter, Phase 2 study of tesetaxel in patients with HER2 negative, HR positive, locally advanced or metastatic breast cancer (LA/MBC) not…NCT03858972·Whittier, California and 24 others

RecruitingA Phase 1 Study of IM-1617 in Participants With Advanced CancerThis study will test the safety and effectiveness of a drug called IM-1617 in participants with solid tumors.NCT07578571·New Haven, Connecticut and 4 others

WithdrawnA Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical CareProject Lets start will provide individual support to breast cancer patients with the goal of reducing delay to chemotherapy initiation.NCT05488444·Houston, Texas

Active not recruitingStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsThis is an open-label, Phase 1/2 multicenter dose escalation study in pediatric patients with relapsed or refractory extracranial solid tumors (Phase 1), with additional expansion…NCT02650401·La Jolla, California and 25 others

Active not recruitingDecision Aid Website in Helping to Make Decisions About Fertility in Participants With CancerThis trial studies how well a decision aid website works in helping to make decisions about fertility in participants with cancer.NCT03141437·Houston, Texas

Active not recruitingPre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)This research trial is studying a combination of neoadjuvant radiotherapy (RT), immunotherapy (pembrolizumab) and chemotherapy for lymph node-positive, triple negative (TN) or…NCT04443348·Washington D.C., District of Columbia and 9 others

CompletedA Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast CancerThis randomized, double-blind, placebo-controlled, two-arm study will assess the safety and efficacy of pertuzumab in addition to chemotherapy plus trastuzumab as adjuvant therapy…NCT01358877·Scottsdale, Arizona and 545 others

CompletedSalud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 1The purpose is to evaluate implementation of a community-based prevention project aimed at increasing early detection and prevention of breast and cervical cancer through…NCT06082505·Houston, Texas

TerminatedStudy of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) ExpressionThis study evaluated ADCT-502 in participants with Advanced Solid Tumors with HER2 Expression.NCT03125200·Palo Alto, California and 4 others

Active not recruitingA Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)This Phase III, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus everolimus compared with the physician's choice of endocrine…NCT05306340·Anchorage, Alaska and 135 others

CompletedEverolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive PatientsThis phase I trial studies the side effects and best dose of everolimus and trastuzumab when given together with letrozole in treating patients with hormone receptor-positive and…NCT02152943·Houston, Texas and 4 others

TerminatedA Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor ReceptorThis is an open-label, Phase I, dose escalation study to determine the recommended Phase 2 dose, maximum tolerated dose, and evaluate the safety and pharmacokinetic profile of…NCT02365662·Boston, Massachusetts and 4 others

TerminatedStudy of AFP464 +/- Faslodex in ER + Breast CancerAFP464 is an investigational agent which may be effective in the treatment of cancer.NCT01233947·Dallas, Texas

CompletedAn Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast CancerThe purpose of this study is to determine if ganetespib (STA-9090) is effective in the treatment of patients with HER2+ or triple negative breast cancer who have not received…NCT01677455·Birmingham, Alabama and 24 others

RecruitingTesting the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid TumorsThis phase I trial tests the safety, side effects, and best dose of ZEN003694 when given together with abemaciclib in treating patients with NUT carcinoma, breast cancer or other…NCT05372640·Los Angeles, California and 6 others

CompletedA Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid TumorsThis will be a Phase 1, open label, 2-sequence, crossover study to establish the BE of the current commercial formulation (Generation 3.1 talazoparib capsules) to the proposed…NCT04672460·Encinitas, California and 30 others

PreviousPage 61 of 89Next

Other Conditions in Texas

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma